This inventor holds 2 USPTO granted patents. Top assignee: Other. Active years: 1976.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Eime ub. Elze, DE (1976)
- Kheden, DE (1976)
Company Filing History:
2 out of 834,570 Years Active: 1976
Title: Oskar Rohte: Innovator in Pharmaceutical Chemistry
Introduction
Oskar Rohte is a notable inventor based in Munich, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds aimed at improving health outcomes.
Latest Patents
Rohte holds 2 patents that showcase his innovative work. His latest patents include "Esters of 5-n-butylpyridine-2 carboxylic acid," which demonstrates superior efficacy in reducing mammalian hypertension compared to the free acid. Another significant patent is "1,3-BIS(Beta-ethylhexyl)-5-amino-5-methylhexahydropyrimidine-pyridine," which exhibits greater bacteriostatic activity and lower toxicity compared to hexetidine or its salts. This compound is prepared by reacting hexetidine or an acid addition salt with nicotinic acid in an organic solvent.
Career Highlights
Throughout his career, Oskar Rohte has focused on creating pharmaceutical innovations that address critical health issues. His work has been instrumental in advancing the understanding and treatment of various medical conditions.
Collaborations
Rohte has collaborated with esteemed colleagues such as Manfred Tauscher and Joachim E. Goring. These partnerships have further enriched his research and development efforts.
Conclusion
Oskar Rohte's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the field positively, paving the way for future innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile